Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies France

Research

Date range: 1 November 2020 - 31 October 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies published between 1 November 2020 - 31 October 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies
Count Share
1 0.12

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.12

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.79 0.08 1.05 0.00 0.36

Compare Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies with other institutions

Collaboration

Date range: 1 November 2020 - 31 October 2021

International vs. domestic collaboration by Share

  • 72.69% Domestic
  • 27.31% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies by Share (23 total)

  1. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and University of Paris-Saclay (0.23)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.12
    University of Paris-Saclay0.12
  2. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and University of Paris-Sud (UPSud) (0.21)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.12
    University of Paris-Sud (UPSud)0.10
  3. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Assistance Publique-Hôpitaux de Paris (AP-HP) (0.16)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.12
    Assistance Publique-Hôpitaux de Paris (AP-HP)0.05
  4. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and National Institute for Health and Medical Research (INSERM) (0.15)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.12
    National Institute for Health and Medical Research (INSERM)0.03
  5. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Marie Lannelongue Hospital (0.14)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.12
    Marie Lannelongue Hospital0.02
  6. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Institut Mines-Télécom (IMT) (0.12)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.12
    Institut Mines-Télécom (IMT)0.01
  7. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Superior National School of Advanced Techniques (ENSTA ParisTech) (0.12)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.12
    Superior National School of Advanced Techniques (ENSTA ParisTech)0.01
  8. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and National Research Institute for Agriculture, Food and Environment (INRAE) (0.12)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.12
    National Research Institute for Agriculture, Food and Environment (INRAE)0.01
  9. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and National Office for Aerospace Studies and Research (ONERA) (0.12)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.12
    National Office for Aerospace Studies and Research (ONERA)0.01
  10. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and National Institute for Research in Computer Science and Control (INRIA) (0.12)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.12
    National Institute for Research in Computer Science and Control (INRIA)0.01

Top 10 international collaborators with Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies by Share (4 total)

  1. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Kobe Pharmaceutical University (0.35)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.12
    Kobe Pharmaceutical University0.23
  2. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Kobe University (0.32)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.12
    Kobe University0.20
  3. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and University of Tsukuba (0.32)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.12
    University of Tsukuba0.20
  4. Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies and Kyoto Prefectural University of Medicine (KPUM) (0.18)
    Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies0.12
    Kyoto Prefectural University of Medicine (KPUM)0.07